Wealth Quarterback LLC Biogen Inc. Transaction History

Wealth Quarterback LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$187.54 - $223.02 $9,189 - $10,927	-49 Closed	0 $0
Q3 2021 Nov 17, 2021	SELL	$282.99 - $369.05 $1,697 - $2,214	-6 Reduced 10.91%	49 $14,000
Q2 2021 Aug 11, 2021	BUY	$259.0 - $414.71 $14,245 - $22,809	55 New	55 $20,000
Q2 2020 Aug 17, 2020	SELL	$258.66 - $342.55 $12,674 - $16,784	-49 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$268.85 - $341.04 $5.99 Million - $7.6 Million	-22,292 Reduced 99.78%	49 $15,000
Q4 2019 Feb 27, 2020	BUY	$220.06 - $304.07 $4.92 Million - $6.79 Million	22,341 New	22,341 $6.63 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Wealth Quarterback LLC, based on Form 13F filings with the SEC.

Stay updated on Wealth Quarterback LLC with notifications on news.